Breast Cancer Research and Treatment

, Volume 116, Issue 1, pp 171–177 | Cite as

Factors predicting in-breast tumor recurrence after breast-conserving surgery

  • Robert Mechera
  • Carsten T. Viehl
  • Daniel OertliEmail author
Clinical Trial


Purpose: The main objectives of this study were to identify risk factors for local in-breast tumor recurrence after breast-conservation and to evaluate the impact of IBTR (in-breast tumor recurrence) on overall survival. Methods: A total of 335 consecutive patients with 346 invasive and in situ breast cancers were treated with breast conserving therapy. Univariate and multivariate statistical analysis were performed and survival rates were calculated and analyzed using the Kaplan–Meier method. Results: With a median follow-up period of 70.6 months 14 patients (4%) developed an IBTR. Overall survival and the disease-free 8-year actuarial survival of patients were 95% and 93%, respectively. The overall survival of patients with tumour recurrence on any site was significantly shorter than of those without recurrence (64% versus 85% after 8 years of follow-up; P < 0.0001). Similarly, overall survival was significantly reduced in patients with distant metastases compared to all others without distant disease (88% versus 40% after 8 years; P < 0.0001). In contrast, overall survival of patients who experienced IBTR did not differ significantly from the group of patients who never developed IBTR (87% versus 70% after 8 years of follow-up). By univariate analysis, lobular carcinoma, high grade tumours, multifocality, concomitant LCIS and DCIS, the absence of estrogene and progesterone receptor status, as well as R1-status, were significant predictors of IBTR. By multivariate analysis, only R1-status (P < 0.002) and the presence of LCIS around the invasive tumour (P < 0.03) remained as significant factors predicting IBTR. Conclusions: Concomitant lobular carcinomas in situ, as well as R1 surgical status are independent significant risk factors for in breast tumor recurrence after breast conserving therapy.


Breast neoplasms Surgery Breast conservation Tumour recurrence Survival Radiotherapy 


  1. 1.
    Fisher B, Redmond C, Poisson R et al (1989) Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 320(13):822–828PubMedGoogle Scholar
  2. 2.
    Veronesi U, Salvadori B, Luini A et al (1990) Conservative treatment of early breast cancer. Long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy. Ann Surg 211(3):250–259PubMedGoogle Scholar
  3. 3.
    Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N (2002) Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N Engl J Med 347(8):567–575. doi: 10.1056/NEJMoa020128 PubMedCrossRefGoogle Scholar
  4. 4.
    Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347(16):1227–1232. doi: 10.1056/NEJMoa020989 PubMedCrossRefGoogle Scholar
  5. 5.
    Gage I, Schnitt SJ, Nixon AJ et al (1996) Pathologic margin involvement and the risk of recurrence in patients treated with breast-conserving therapy 13. Cancer 78(9):1921–1928. doi:10.1002/(SICI)1097-0142(19961101)78:9<1921::AID-CNCR12>3.0.CO;2-#PubMedCrossRefGoogle Scholar
  6. 6.
    Smitt MC, Nowels KW, Zdeblick MJ et al (1995) The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 76(2):259–267. doi:10.1002/1097-0142(19950715)76:2<259::AID-CNCR2820760216>3.0.CO;2-2PubMedCrossRefGoogle Scholar
  7. 7.
    Wazer DE, Jabro G, Ruthazer R, Schmid C, Safaii H, Schmidt-Ullrich RK (1999) Extent of margin positivity as a predictor for local recurrence after breast conserving irradiation. Radiat Oncol Investig 7(2):111–117. doi:10.1002/(SICI)1520-6823(1999)7:2<111::AID-ROI7>3.0.CO;2-UPubMedCrossRefGoogle Scholar
  8. 8.
    Huang E, Buchholz TA, Meric F et al (2002) Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer 95(10):2059–2067. doi: 10.1002/cncr.10952 PubMedCrossRefGoogle Scholar
  9. 9.
    Dixon JM, Gregory K, Johnston S, Rodger A (2002) Breast cancer: non-metastatic. Clin Evid 8:1811–1839PubMedGoogle Scholar
  10. 10.
    Kurtz JM (1992) Factors influencing the risk of local recurrence in the breast. Eur J Cancer 28(2–3):660–666. doi: 10.1016/S0959-8049(05)80121-2 PubMedCrossRefGoogle Scholar
  11. 11.
    Elkhuizen PH, van Slooten HJ, Clahsen PC et al (2000) High local recurrence risk after breast-conserving therapy in node-negative premenopausal breast cancer patients is greatly reduced by one course of perioperative chemotherapy: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol 18(5):1075–1083PubMedGoogle Scholar
  12. 12.
    Locker AP, Ellis IO, Morgan DA, Elston CW, Mitchell A, Blamey RW (1989) Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76(9):890–894. doi: 10.1002/bjs.1800760906 PubMedCrossRefGoogle Scholar
  13. 13.
    Kurtz JM, Jacquemier J, Amalric R et al (1990) Risk factors for breast recurrence in premenopausal and postmenopausal patients with ductal cancers treated by conservation therapy. Cancer 65(8):1867–1878. doi:10.1002/1097-0142(19900415)65:8<1867::AID-CNCR2820650833>3.0.CO;2-IPubMedCrossRefGoogle Scholar
  14. 14.
    Lindley R, Bulman A, Parsons P, Phillips R, Henry K, Ellis H (1989) Histologic features predictive of an increased risk of early local recurrence after treatment of breast cancer by local tumor excision and radical radiotherapy. Surgery 105(1):13–20PubMedGoogle Scholar
  15. 15.
    Clarke DH, Le MG, Sarrazin D et al (1985) Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11(1):137–145PubMedGoogle Scholar
  16. 16.
    Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, Wolmark N (2004) Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project: twelve-year observations concerning lobular carcinoma in situ. Cancer 100(2):238–244. doi: 10.1002/cncr.11883 PubMedCrossRefGoogle Scholar
  17. 17.
    Fourquet A, Campana F, Zafrani B et al (1989) Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17(4):719–725PubMedGoogle Scholar
  18. 18.
    Boyages J, Recht A, Connolly J et al (1989) Factors associated with local recurrence as a first site of failure following the conservative treatment of early breast cancer. Recent Results Cancer Res 115:92–102PubMedGoogle Scholar
  19. 19.
    Eberlein TJ, Connolly JL, Schnitt SJ, Recht A, Osteen RT, Harris JR (1990) Predictors of local recurrence following conservative breast surgery and radiation therapy. The influence of tumor size. Arch Surg 125(6):771–775PubMedGoogle Scholar
  20. 20.
    Jacquemier J, Kurtz JM, Amalric R, Brandone H, Ayme Y, Spitalier JM (1990) An assessment of extensive intraductal component as a risk factor for local recurrence after breast-conserving therapy. Br J Cancer 61(6):873–876PubMedGoogle Scholar
  21. 21.
    Rose MA, Henderson IC, Gelman R et al (1989) Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure. Int J Radiat Oncol Biol Phys 17(4):711–717PubMedGoogle Scholar
  22. 22.
    Langer I, Marti WR, Guller U et al (2005) Axillary recurrence rate in breast cancer patients with negative sentinel lymph node (SLN) or SLN micrometastases: prospective analysis of 150 patients after SLN biopsy. Ann Surg 241(1):152–158PubMedGoogle Scholar
  23. 23.
    Goldhirsch A, Wood WC, Gelber RD, Coates AS, Thurlimann B, Senn HJ (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18(7):1133–1144. doi: 10.1093/annonc/mdm271 PubMedCrossRefGoogle Scholar
  24. 24.
    Guth U, Singer G, Langer I et al (2006) T4 category revision enhances the accuracy and significance of stage III breast cancer. Cancer 106(12):2569–2575. doi: 10.1002/cncr.21920 PubMedCrossRefGoogle Scholar
  25. 25.
    Cabioglu N, Hunt KK, Buchholz TA et al (2005) Improving local control with breast-conserving therapy: a 27-year single-institution experience 19. Cancer 104(1):20–29. doi: 10.1002/cncr.21121 PubMedCrossRefGoogle Scholar
  26. 26.
    Komoike Y, Akiyama F, Iino Y et al (2006) Ipsilateral breast tumor recurrence (IBTR) after breast-conserving treatment for early breast cancer: risk factors and impact on distant metastases. Cancer 106(1):35–41. doi: 10.1002/cncr.21551 PubMedCrossRefGoogle Scholar
  27. 27.
    Haffty BG, Reiss M, Beinfield M, Fischer D, Ward B, McKhann C (1996) Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 14(1):52–57PubMedGoogle Scholar
  28. 28.
    Nottage MK, Kopciuk KA, Tzontcheva A, Andrulis IL, Bull SB, Blackstein ME (2006) Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with node-negative breast cancer: a prospective cohort study. Breast Cancer Res 8(4):R44. doi: 10.1186/bcr1531 PubMedCrossRefGoogle Scholar
  29. 29.
    Elder EE, Kennedy CW, Gluch L et al (2006) Patterns of breast cancer relapse. Eur J Surg Oncol 32(9):922–927. doi: 10.1016/j.ejso.2006.06.001 PubMedCrossRefGoogle Scholar
  30. 30.
    Fortin A, Larochelle M, Laverdiere J, Lavertu S, Tremblay D (1999) Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy. J Clin Oncol 17(1):101–109PubMedGoogle Scholar
  31. 31.
    Park CC, Mitsumori M, Nixon A et al (2000) Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence 21. J Clin Oncol 18(8):1668–1675PubMedGoogle Scholar
  32. 32.
    Meric F, Mirza NQ, Vlastos G et al (2003) Positive surgical margins and ipsilateral breast tumor recurrence predict disease-specific survival after breast-conserving therapy. Cancer 97(4):926–933. doi: 10.1002/cncr.11222 PubMedCrossRefGoogle Scholar
  33. 33.
    Abner AL, Connolly JL, Recht A et al (2000) The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 88(5):1072–1077. doi:10.1002/(SICI)1097-0142(20000301)88:5<1072::AID-CNCR18>3.0.CO;2-DPubMedCrossRefGoogle Scholar
  34. 34.
    Jolly S, Kestin LL, Goldstein NS, Vicini FA (2006) The impact of lobular carcinoma in situ in association with invasive breast cancer on the rate of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 66(2):365–371. doi: 10.1016/j.ijrobp.2006.05.070 PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2008

Authors and Affiliations

  • Robert Mechera
    • 1
  • Carsten T. Viehl
    • 1
  • Daniel Oertli
    • 1
    Email author
  1. 1.Department of SurgeryUniversity Hospital BaselBaselSwitzerland

Personalised recommendations